Sfoglia per Autore
Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients.
file con accesso da definire2007 Gemmati, Donato; Federici, Federica; Campo, Gianluca Calogero; Tognazzo, Silvia; Serino, Maria Luisa; DE MATTEI, Monica; Valgimigli, Marco; Malagutti, Patrizia; Guardigli, Gabriele; Ferraresi, Paolo; Bernardi, Francesco; Ferrari, Roberto; Scapoli, Gian Luigi; Catozzi, Linda
Tissue factor and coagulation factor VII levels during AMI: association with genotype and adverse events
file con accesso da definire2007 S., Luccarelli; A., Frangione; Campo, Gianluca Calogero
Effect of thienopyridines discontinuation on mortality or MI after SES versus BMS implantation in STEMI
file con accesso da definire2007 Arcozzi, C; Valgimigli, M; Campo, Gianluca Calogero; Ferrari, F; Percoco, G.
Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study
2007 Valgimigli, M; Campo, Gianluca Calogero; Arcozzi, C; Malagutti, P; Carletti, R; Ferrari, F; Barbieri, D; Parrinello, G; Percoco, G; Ferrari, Roberto
Poor responsiveness to clopidogrel. Drug-specific or class-effect?
2007 Frangione, A.; Luccarelli, S.; Campo, Gianluca Calogero; Valgimigli, M.; Ferrari, Roberto
Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study
2007 Campo, Gianluca Calogero; Valgimigli, Marco; Gemmati, Donato; Percoco, Giovanni; Catozzi, Linda; Frangione, Alice; Federici, Federica; Ferrari, F; Tebaldi, Matteo; Luccarelli, S; Parrinello, G; Ferrari, Roberto
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial
2008 Valgimigli, M; Campo, Gianluca Calogero; Percoco, G; Bolognese, L; Vassanelli, C; Colangelo, S; de Cesare, N; Rodriguez, Ae; Ferrario, M; Moreno, R; Piva, T; Sheiban, I; Pasquetto, G; Prati, F; Nazzaro, Ms; Parrinello, G; Ferrari, Roberto
A Strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction.
file con accesso da definire2008 M., Valgimigli; N., Mittmann; D. J., Cohen; Campo, Gianluca Calogero; P. K., Isogai; S. J., Seung; B., Dulisse; C., Arcozzi; P., Squasi; G., Percoco; Ferrari, Roberto
Prognostic value of serial platelet reactivity measurements on long-term clinical outcome in patients with ST-elevation myocardial infarction undergoing primary PCI
file con accesso da definire2008 Campo, Gianluca Calogero; Valgimigli, M; Frangione, A; Tebaldi, M; Ferrari, Roberto
Tailoring treatment with tirofiban in aptients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design
file con accesso da definire2008 M., Valgimigli; Campo, Gianluca Calogero; N., De Cesare; P., Vranckx; M., Hamon; Dj, Angiolillo; M., Sabatè; Ferrari, Roberto; A., Furgieri; C., Tumscitz; A., Repetto; S., Colangelo; E., Meliga; M., Kubbajeh; G., Parrinello; G., Percoco; F., Ferrari
Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction
file con accesso da definire2009 Ferraresi, Paolo; Campo, Gianluca Calogero; Marchetti, Giovanna; Pinotti, Mirko; Valgimigli, Marco; Gemmati, Donato; Ferrari, Roberto; Bernardi, Francesco
The 5-Year Clinical Outcomes After a Randomized Comparison of Sirolimus-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction
file con accesso da definire2009 Tebaldi, M.; Arcozzi, C.; Campo, G.; Percoco, G.; Ferrari, R.; Valgimigli, M.
Mechanisms of remodelling: a question of life (stem cell production) and death (myocyte apoptosis).
file con accesso da definire2009 Ferrari, Roberto; Ceconi, Claudio; Campo, Gianluca Calogero; Cangiano, Elisa; Cavazza, Caterina; Secchiero, Paola; Tavazzi, L.
Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry
file con accesso da definire2009 Saia, F; Piovaccari, G; Manari, A; Guastaroba, P; Vignali, L; Varani, E; Santarelli, A; Benassi, A; Liso, A; Campo, Gianluca Calogero; Tondi, S; Tarantino, F; De Palma, R; Marzocchi, A.
Long-term outcome after percutaneous coronary intervention in patients with essential thrombocythemia
file con accesso da definire2009 Campo, Gianluca Calogero; Valgimigli, M; Carletti, R; Fileti, L; Ferrari, Roberto
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study
2009 Valgimigli, M; Campo, Gianluca Calogero; de Cesare, N; Meliga, E; Vranckx, P; Furgieri, A; Angiolillo, Dj; Sabatè, M; Hamon, M; Repetto, A; Colangelo, S; Brugaletta, S; Parrinello, G; Percoco, G; Ferrari, Roberto
Current options to manage clopidogrel poor responsiveness
file con accesso da definire2010 Fileti, L; Campo, Gianluca Calogero; Valgimigli, M; Marchesini, J; Ferrari, Roberto
Randomized comparison of 6-versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY)
file con accesso da definire2010 Valgimigli, M; Campo, Gianluca Calogero; Percoco, G; Monti, M; Ferrari, F; Tumscitz, C; Zuffi, A; Colombo, F; Kubbajeh, M; Cavazza, C; Cangiano, E; Tebaldi, M; Minarelli, M; Arcozzi, C; Scalone, A; Frangione, A; Borghesi, M; Marchesini, J; Parrinello, G; Ferrari, Roberto
Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting
file con accesso da definire2010 M., Valgimigli; Campo, Gianluca Calogero; Tebaldi, Matteo; M., Monti; Gambetti, S.; Scalone, Antonella; G., Parrinello; Ferrari, Roberto; ON BEHALF OF THE FABOLUS SYNCHRO, Investigators
Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting
2010 Campo, Gianluca Calogero; Valgimigli, M; Carrescia, C; Carletti, R; Ferrari, Roberto
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Factor XIIIA-V34L and factor XIIIB-H95R gene variants: effects on survival in myocardial infarction patients. | 2007 | Gemmati, Donato; Federici, Federica; Campo, Gianluca Calogero; Tognazzo, Silvia; Serino, Maria Lu...isa; DE MATTEI, Monica; Valgimigli, Marco; Malagutti, Patrizia; Guardigli, Gabriele; Ferraresi, Paolo; Bernardi, Francesco; Ferrari, Roberto; Scapoli, Gian Luigi; Catozzi, Linda | file con accesso da definire |
| Tissue factor and coagulation factor VII levels during AMI: association with genotype and adverse events | 2007 | S., Luccarelli; A., Frangione; Campo, Gianluca Calogero | file con accesso da definire |
| Effect of thienopyridines discontinuation on mortality or MI after SES versus BMS implantation in STEMI | 2007 | Arcozzi, C; Valgimigli, M; Campo, Gianluca Calogero; Ferrari, F; Percoco, G. | file con accesso da definire |
| Two-year clinical follow-up after sirolimus-eluting versus bare-metal stent implantation assisted by systematic glycoprotein IIb/IIIa Inhibitor Infusion in patients with myocardial infarction: results from the STRATEGY study | 2007 | Valgimigli, M; Campo, Gianluca Calogero; Arcozzi, C; Malagutti, P; Carletti, R; Ferrari, F; Barbi...eri, D; Parrinello, G; Percoco, G; Ferrari, Roberto | |
| Poor responsiveness to clopidogrel. Drug-specific or class-effect? | 2007 | Frangione, A.; Luccarelli, S.; Campo, Gianluca Calogero; Valgimigli, M.; Ferrari, Roberto | |
| Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study | 2007 | Campo, Gianluca Calogero; Valgimigli, Marco; Gemmati, Donato; Percoco, Giovanni; Catozzi, Linda; ...Frangione, Alice; Federici, Federica; Ferrari, F; Tebaldi, Matteo; Luccarelli, S; Parrinello, G; Ferrari, Roberto | |
| Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trial | 2008 | Valgimigli, M; Campo, Gianluca Calogero; Percoco, G; Bolognese, L; Vassanelli, C; Colangelo, S; d...e Cesare, N; Rodriguez, Ae; Ferrario, M; Moreno, R; Piva, T; Sheiban, I; Pasquetto, G; Prati, F; Nazzaro, Ms; Parrinello, G; Ferrari, Roberto | |
| A Strategy to offset the extra cost of sirolimus-eluting stent in patients undergoing intervention for acute myocardial infarction. | 2008 | M., Valgimigli; N., Mittmann; D. J., Cohen; Campo, Gianluca Calogero; P. K., Isogai; S. J., Seung...; B., Dulisse; C., Arcozzi; P., Squasi; G., Percoco; Ferrari, Roberto | file con accesso da definire |
| Prognostic value of serial platelet reactivity measurements on long-term clinical outcome in patients with ST-elevation myocardial infarction undergoing primary PCI | 2008 | Campo, Gianluca Calogero; Valgimigli, M; Frangione, A; Tebaldi, M; Ferrari, Roberto | file con accesso da definire |
| Tailoring treatment with tirofiban in aptients showing resistance to aspirin and/or resistance to clopidogrel (3T/2R). Rationale for the study and protocol design | 2008 | M., Valgimigli; Campo, Gianluca Calogero; N., De Cesare; P., Vranckx; M., Hamon; Dj, Angiolillo; ...M., Sabatè; Ferrari, Roberto; A., Furgieri; C., Tumscitz; A., Repetto; S., Colangelo; E., Meliga; M., Kubbajeh; G., Parrinello; G., Percoco; F., Ferrari | file con accesso da definire |
| Temporal and genotype-driven variations of factor VII levels in patients with acute myocardial infarction | 2009 | Ferraresi, Paolo; Campo, Gianluca Calogero; Marchetti, Giovanna; Pinotti, Mirko; Valgimigli, Marc...o; Gemmati, Donato; Ferrari, Roberto; Bernardi, Francesco | file con accesso da definire |
| The 5-Year Clinical Outcomes After a Randomized Comparison of Sirolimus-Eluting Versus Bare-Metal Stent Implantation in Patients With ST-Segment Elevation Myocardial Infarction | 2009 | Tebaldi, M.; Arcozzi, C.; Campo, G.; Percoco, G.; Ferrari, R.; Valgimigli, M. | file con accesso da definire |
| Mechanisms of remodelling: a question of life (stem cell production) and death (myocyte apoptosis). | 2009 | Ferrari, Roberto; Ceconi, Claudio; Campo, Gianluca Calogero; Cangiano, Elisa; Cavazza, Caterina; ...Secchiero, Paola; Tavazzi, L. | file con accesso da definire |
| Patient selection to enhance the long-term benefit of first generation drug-eluting stents for coronary revascularisation procedures. Insights from a large multicentre registry | 2009 | Saia, F; Piovaccari, G; Manari, A; Guastaroba, P; Vignali, L; Varani, E; Santarelli, A; Benassi, ...A; Liso, A; Campo, Gianluca Calogero; Tondi, S; Tarantino, F; De Palma, R; Marzocchi, A. | file con accesso da definire |
| Long-term outcome after percutaneous coronary intervention in patients with essential thrombocythemia | 2009 | Campo, Gianluca Calogero; Valgimigli, M; Carletti, R; Fileti, L; Ferrari, Roberto | file con accesso da definire |
| Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: Results from the double-blind, prospective, randomized tailoring treatment with tirofiban in patients showing resistance to aspirin and/or resistance to clopidogrel study | 2009 | Valgimigli, M; Campo, Gianluca Calogero; de Cesare, N; Meliga, E; Vranckx, P; Furgieri, A; Angiol...illo, Dj; Sabatè, M; Hamon, M; Repetto, A; Colangelo, S; Brugaletta, S; Parrinello, G; Percoco, G; Ferrari, Roberto | |
| Current options to manage clopidogrel poor responsiveness | 2010 | Fileti, L; Campo, Gianluca Calogero; Valgimigli, M; Marchesini, J; Ferrari, Roberto | file con accesso da definire |
| Randomized comparison of 6-versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY) | 2010 | Valgimigli, M; Campo, Gianluca Calogero; Percoco, G; Monti, M; Ferrari, F; Tumscitz, C; Zuffi, A;... Colombo, F; Kubbajeh, M; Cavazza, C; Cangiano, E; Tebaldi, M; Minarelli, M; Arcozzi, C; Scalone, A; Frangione, A; Borghesi, M; Marchesini, J; Parrinello, G; Ferrari, Roberto | file con accesso da definire |
| Randomized, double-blind comparison of effects of abiciximab bolus only vs. on-label regimen on ex vivo inhibition of platelet aggregation in responders to clopidogrel undergoing coronary stenting | 2010 | M., Valgimigli; Campo, Gianluca Calogero; Tebaldi, Matteo; M., Monti; Gambetti, S.; Scalone, Anto...nella; G., Parrinello; Ferrari, Roberto; ON BEHALF OF THE FABOLUS SYNCHRO, Investigators | file con accesso da definire |
| Tailored Medical and Interventional Therapy Against Recurrent Stent Thrombosis After Drug-Eluting Stenting | 2010 | Campo, Gianluca Calogero; Valgimigli, M; Carrescia, C; Carletti, R; Ferrari, Roberto |
Legenda icone
- file ad accesso aperto
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile